Found: 24
Select item for more details and to access through your institution.
Germline evaluation of patients undergoing tumor genomic profiling: An academic cancer center's experience with implementing a germline review protocol.
- Published in:
- Journal of Genetic Counseling, 2021, v. 30, n. 3, p. 900, doi. 10.1002/jgc4.1392
- By:
- Publication type:
- Article
The Prevalence and Influence of New or Worsened Neck Pain After a Sport-Related Concussion in Collegiate Athletes: A Study From the CARE Consortium.
- Published in:
- American Journal of Sports Medicine, 2024, v. 52, n. 7, p. 1845, doi. 10.1177/03635465241247212
- By:
- Publication type:
- Article
SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0875-3
- By:
- Publication type:
- Article
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. E276, doi. 10.1002/ajh.26580
- By:
- Publication type:
- Article
Cardiovascular hospitalizations and mortality among adults aged 25–64 years in the USA.
- Published in:
- European Heart Journal, 2024, v. 45, n. 12, p. 1017, doi. 10.1093/eurheartj/ehad772
- By:
- Publication type:
- Article
Retraction Note to: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.
- Published in:
- Molecular Cancer, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12943-018-0931-9
- By:
- Publication type:
- Article
Breast adenoid cystic carcinoma in a 19-year-old man: a case report and review of the literature.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation.
- Published in:
- Molecular Cancer, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12943-020-1145-5
- By:
- Publication type:
- Article
Extracorporeal membrane oxygenation for COVID‐19: An evolving experience through multiple waves.
- Published in:
- Artificial Organs, 2022, v. 46, n. 11, p. 2257, doi. 10.1111/aor.14381
- By:
- Publication type:
- Article
Impact of Preoperative vs Postoperative Radiotherapy on Overall Survival of Locally Advanced Breast Cancer Patients.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.779185
- By:
- Publication type:
- Article
microRNA‐128‐3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down‐regulating NEK2.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 13, p. 7353, doi. 10.1111/jcmm.15317
- By:
- Publication type:
- Article
Long non‐coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation.
- Published in:
- Journal of Cellular & Molecular Medicine, 2018, v. 22, n. 10, p. 4935, doi. 10.1111/jcmm.13758
- By:
- Publication type:
- Article
Budesonide Prophylaxis Reduces the Risk of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 10, p. e775, doi. 10.1016/j.clml.2021.06.004
- By:
- Publication type:
- Article
Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer.
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5382
- By:
- Publication type:
- Article
Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer.
- Published in:
- International Journal of Oncology, 2018, v. 53, n. 3, p. 1013, doi. 10.3892/ijo.2018.4467
- By:
- Publication type:
- Article
Retraction Note: Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 11, p. 1, doi. 10.1038/s41419-023-06254-5
- By:
- Publication type:
- Article
Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41419-020-2250-5
- By:
- Publication type:
- Article
Bioinformatic analysis and experimental validation of six cuproptosis-associated genes as a prognostic signature of breast cancer.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.17419
- By:
- Publication type:
- Article
Corrigendum: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/b-Catenin Signaling Pathway Activation.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Progression of frailty and cardiovascular outcomes among Medicare beneficiaries.
- Published in:
- Journal of the American Geriatrics Society, 2024, v. 72, n. 10, p. 3129, doi. 10.1111/jgs.19116
- By:
- Publication type:
- Article
Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.533176
- By:
- Publication type:
- Article